Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local-made risperidone solution versus original Risperdal solution in autism spectrum disorder
TCTR20180414001Enrolling by invitation
- Sponsor
- No
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of risperidone in Autism Spectrum Disorder (ASD) (2 arms), sponsored by No. Primary endpoint: Efficacy comparison at 6 months. Started Jun 2017; status: enrolling by invitation.
02
Drugs
risperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on TCTR20180414001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180414001.